Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors

I Moodley1, Y Sotsios, B Bertin

  • 1Institut de Recherche Jouveinal 9 rue de la Loge Fresnes Cedex 94265 France.

Insights

Phosphodiesterase (PDE) inhibitors, including rolipram and Ro 20-1724, demonstrated dose-dependent inhibition of contact hypersensitivity (CS) in mice. These findings suggest PDE IV isozymes are key mediators in CS by suppressing lymphocyte activation.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Contact hypersensitivity (CS) is an immune response mediated by T-cells.
  • Phosphodiesterase (PDE) enzymes regulate intracellular signaling pathways involved in immune cell activation.

Purpose of the Study:

  • To investigate the efficacy of various PDE inhibitors in modulating oxazolone-induced contact hypersensitivity in a murine model.
  • To assess the impact of PDE inhibitors on lymphocyte proliferation.

Main Methods:

  • Mice were treated with different PDE inhibitors (e.g., rolipram, Ro 20-1724, theophylline, milrinone, SKF 94836, zaprinast) prior to oxazolone challenge to measure CS inhibition.
  • In vitro assays were performed to determine the IC(50) values of selected PDE inhibitors against mouse lymphoblast proliferation.

Main Results:

  • Rolipram, Ro 20-1724, and theophylline dose-dependently inhibited CS, with ED(30) values of 2.1, 5.4, and 30.4 mg/kg, respectively.
  • Rolipram and Ro 20-1724 significantly inhibited lymphocyte proliferation (IC(50) = 0.08 µM and 0.83 µM, respectively).
  • Other PDE inhibitors showed varying degrees of inhibition, with betamethasone and indomethacin serving as positive controls.

Conclusions:

  • PDE IV isozymes appear to play a significant role in mediating contact hypersensitivity.
  • Inhibition of PDE IV may represent a therapeutic strategy for managing T-cell-mediated inflammatory conditions like CS.